Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial

Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page displays the study record for the Phase I LMB-100 pleural cancer trial, including its withdrawn status with no participants enrolled, eligibility criteria, treatment plan, and outcome measures.
    Difference
    58%
    Check dated 2026-11-08T06:18:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T04:57:19.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says the agency is using “Super Intelligence” in place of “Artificial Intelligence.” It appears above the page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-25T06:46:11.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site's displayed revision advances from v3.7.1 to v3.7.2; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T06:50:15.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1, while the study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T08:44:09.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, including a DOCTYPE, a 403 title, and a Home link. This replaces the previous study details with a simple error layout.
    Difference
    20%
    Check dated 2026-09-20T04:23:14.000Z thumbnail image

Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.